Other languages Notable Labs, Ltd.

Equities

NTBL

IL0012002452

End-of-day quote Nasdaq Other stock markets 23:00:00 26/06/2024 BST			5-day change	1st Jan Change
0.671 ^USD	+5.62%		-10.77%	-64.50%

06-24	Notable Labs, Ltd.(NasdaqCM:NTBL) added to S&P TMI Index	CI
05-16	Chardan Cuts Price Target on Notable Labs to $5 From $7 on Higher Expected Share Count Dilution, Keeps Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Il coefficiente di Nakamoto: l'arma definitiva della decentralizzazione?	05-29
Notable Labs, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15
Notable Labs, Ltd. Presents the Design Plan for the Ppmp-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	04-09
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay At AACR 2024 Expands the Potential of the Platform	04-08
OPINIONES DE LOS ANALISTAS DEL DÍA : Stellantis, Aena, Richemont, Adyen, Fraport, BBVA, Aperam, Enagás, Sacyr, BE Semi...	04-02
Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	02-22
Top Premarket Gainers	01-09
Notable Labs, Ltd. and CicloMed LLC Announces Initial Safety and Efficacy Data of Fosciclopirox and the Performance of PPMP	12-18
Vascular Biogenics, Notable Labs Complete Merger	16/10/23
Notable Labs, Inc. completed the acquisition of Vascular Biogenics Ltd. from Aurum Ventures MKI Ltd. and others in reverse merger transaction.	15/10/23
Vascular Biogenics Ltd. Approves Board Appointments	12/10/23
Vascular Biogenics Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Vascular Biogenics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Vascular Biogenics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
An unknown buyer completed the acquisition of Manufacturing facility in Modiin, Israel and certain related assets from Vascular Biogenics Ltd..	08/03/23
Aleph Farms Limited completed the acquisition of manufacturing facility in Israel from Vascular Biogenics Ltd..	08/03/23
Sector Update: Health Care Stocks Finishing with Small Rise	23/02/23
Sector Update: Health Care	23/02/23
Top Midday Gainers	23/02/23
Vascular Biogenics, Notable Labs Sign Merger to Form Nasdaq-Listed Therapeutic Platform Company	23/02/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Notable Labs, Ltd.

Equities

NTBL

IL0012002452

Other languages

Filters